ArticleAnnals of clinical and translational neurology2025

Efficacy and safety of combined low-dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy.

Ying Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.